News
🌏 NMPA Page 12Latest pharmaceutical news, drug approvals, and NMPA regulatory updates
Showing 133–144 of 248 articles
Argo Biopharma Doses First Patient in Phase I Trial of siRNA Therapy BW-50218 for TTR-Related Disease
2 min
Sophie MartinClaruvis Pharmaceutical's Retoxin Becomes World's First Approved Recombinant Botulinum Toxin Type A in China
Dermatology/Aesthetics · 3 min
Sophie MartinJyong Biotech Advances Market Access Strategy for Botanical Drug Botreso® and PCP Pipeline
2 min
Sophie MartinArcera Life Sciences Partners with Fosun Pharma for Neurodegenerative Disease R&D Collaboration
2 min
Sophie MartinSamsung Bioepis Partners with ATLATL Innovation Center to Accelerate Asia-Pacific Biotech Development
2 min
Sophie MartinTGA Updates Comprehensive Regulatory Framework for Implantable Medical Devices in Australia
TGA · 2 min
Sophie MartinImmunic Appoints Dr. Michael Panzara as Chief Medical Officer to Lead Vidofludimus Calcium Development
2 min
Sophie MartinZhengye Biotechnology Reports Fiscal 2025 Financial Results for Veterinary Vaccine Business
2 min
Sophie MartinChinaBio Partnering Forum: Biotech Investment Trends Emerge
biotech · 8 min
Sophie MartinAkso Health Group Launches Brain-Computer Interface R&D Program Targeting Neurotechnology Market
Neurotechnology/Brain-Computer Interface · 3 min
Sophie MartinEvofem Biosciences Secures Exclusive SOLOSEC Distribution Agreement for Sub-Saharan Africa Market
2 min
Sophie MartinPSG 2026 Specialty Drug Benefits Report: Cost Management Remains Top Priority as Coverage Strategies Challenge Payers
2 min
Sophie MartinPopular topics
- Drug Approvals 1,138 articles
- Clinical Trials 652 articles
- Regulatory Updates 695 articles
- Press Releases 443 articles
- Oncology 456 articles
- Mergers & Acquisitions 105 articles
- Rare Diseases 143 articles
Explore intelligence
- Global markets Cross-region command center
- Company directory Sponsor & marketer profiles
- Drug profiles INN & regulatory status
- Clinical trials hub Stage & therapy filters
- Pipeline programs R&D intelligence
- Patent landscape US & EP IP moats
- Event calendar Congress catalysts
- Regulatory reference Submission types & pathways